K. T. Moore and M. Langas, “Use of Rivaroxaban and Apixaban, Two Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), in Renally Impaired Patients - the limits of our knowledge”, J Cardiol Cardiovasc Med, vol. 3, no. 3, pp. 049–051, Oct. 2018.